Department of Medicine
Faculty Profiles by Division

Division of Cardiology

Faculty Profiles

[Return To Index page]
photo Jonathan Holtz, MD


Clinical Assistant Professor of Medicine


Research Interest
My research interests are related to the care of patients with heart failure and pulmonary hypertension. Particular areas of interest include clinical outcomes such as adverse events associated with ventricular assist devices.
Clinical Interest
My clinical interests are in the evaluation and management of patients with heart failure and pulmonary hypertension. This includes patients requiring heart transplantation and mechanical circulatory support such as left ventricular assist devices (LVADs). I have a particular interest in the prevention of patients at risk for developing heart failure.
Selected Publications:
Holtz, JE, Teuteberg, JJ. Long term mechanical support for advanced heart failure. Irwin and Rippe’s Intensive Care Medicine, 8th Edition. 2016; Chapter45.
Holtz, JE, Teuteberg, JJ. Management of aortic insufficiency in the continuous flow left ventricular assist device population. Curr Heart Fail Rep. 2013; 11: 103-110.
Holtz, JE, Sangani, DS, Cohen, BE, Na, B, Schiller, NB, Whooley, MA. Mitral annular calcium, inducible myocardial ischemia, and cardiovascular events in outpatients with coronary heart disease (from the heart and soul study). Am J Cardiol. 2012; 109(8): 1092-6.
Arnold, SV, Jones, PG, Allen, LA, Cohen, DJ, Fendler, TJ, Holtz, JE, Aggarwal, S., Spertus, JA. Frequency of Poor Outcome (Death or Poor Quality of Life) After Left Ventricular Assist Device for Destination Therapy: Results from the INTERMACS Registry. Circ Heart Fail. 2016; in press.
Lampert, BC, Teuteberg, JJ, Shullo, MA, Holtz, JE, Smith, KJ. Cost effectiveness of routine surveillance endomyocardial biopsy beyond 12 months post heart transplantation. Circ Heart Fail. 2014; epub ahead of print.
Henry, BL, Jentzer, JC, Holtz, JE, Chauhan, CA, Rahman, AM. A clinically oriented review of the landmark clinical trials comparing warfarin and aspirin to novel oral anticoagulants in atrial fibrillation. J Cardio Vasc Med. 2014; 4: 402.
Wong, TC, Piehler, KM, Zareba, KM, Lin, K, Phrampus, A, Patel, A, Moon, JC, Ugander, M, Valeti, U, Holtz, JE, Fu, B, Chang, C, Mathier, M, Kellman, P, Butler, J, Gheorghiade, M, Schelbert, E. Myocardial damage detected by late gadolinium enhancement cardiovascular magnetic resonance is associated with subsequent hospitalization for heart failure. J Am Heart Assoc. 2013; 2(6): e000416.
Notable Achievements
The Jeffrey Wierenga Advance Heart Failure/Transplant Fellowship Award, 2016
American Heart Association Fellow Research Day Clinical Presentation Award, 2015
Thomas F. Keliher Award, 2008
Alpha Omega Alpha Society, 2007
Ridings-Gladwin Award, 2005-2008
Phi Beta Kappa Society, 2003
Life Sciences Consortium Scholarship, 2002-2003